AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 102 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $815,570 | +63.4% | 19,965 | +2.1% | 0.01% | +66.7% |
| Q1 2024 | $499,171 | +232.9% | 19,560 | +18.0% | 0.00% | +200.0% |
| Q4 2023 | $149,968 | +45.7% | 16,571 | +2.7% | 0.00% | 0.0% |
| Q3 2023 | $102,922 | -45.1% | 16,132 | -4.6% | 0.00% | -50.0% |
| Q2 2023 | $187,476 | -20.7% | 16,905 | +9.7% | 0.00% | 0.0% |
| Q1 2023 | $236,482 | -3.4% | 15,406 | +39.7% | 0.00% | 0.0% |
| Q4 2022 | $244,778 | +47.5% | 11,031 | +8.8% | 0.00% | 0.0% |
| Q3 2022 | $166,000 | -23.9% | 10,142 | +10.4% | 0.00% | 0.0% |
| Q4 2021 | $218,000 | -5.2% | 9,190 | -1.4% | 0.00% | 0.0% |
| Q3 2021 | $230,000 | – | 9,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
| Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
| COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
| RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
| Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
| Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
| Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
| RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
| EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |